Home >> Industry News >> International News
frontview no frame frontview vmo3D sideview no frame sideview vmo3D
International News
  • Also available via:

OGS Appoints Inaugural Chair of New Global Development Board PDF
Submit Your News
International News
Friday, 22 February 2013

J C AragonOptometry Giving Sight (OGS) has announced that Dr. Juan Carlos Aragon (picture), Senior Vice President, Americas Region for CooperVision, will be the inaugural Chair of the organisation's new Global Development Board (GDB). The Global Development Board has been created at the request of the Board to be a key driver of strategic growth and development in relation to fundraising.

"Dr. Aragon has a very strong commitment to, and understanding of, Optometry Giving Sight, both personally and professionally, and has more than 28 years experience working in the global optical industry," said CEO, Clive Miller. "His knowledge and passion for the development of Optometry and the elimination of refractive error blindness and impaired vision has already inspired colleagues around the world, and we think he will be an excellent Chair of the GDB".

Joining Dr. Aragon on the GDB will be: Claude Darnault – Chief Sustainability Officer, Essilor; Dr. Glenn Ellisor – CEO, Vision Source; Dr. Tony Hanks – Founder and Chairman, Eyecare Plus (Australia); Rob Lynch – CEO, VSP Global; Andrea Saia – Board member, Coca Cola Enterprises; Dr. Al Ulsifer – FYI Eye Doctors; Dr. Rick Weisbarth – VP Professional Affairs, Alcon.

"It's a great honor for me to take on this role and to be working with such an esteemed group of industry leaders," said Dr. Aragon. "I believe that there is so much more that we as an industry can do to ensure that all people have access to affordable eye and vision care. It's a win-win in my view – we promote the importance of good vision and an effective vision care industry, while helping millions of people around the world realize their potential by being able to see clearly."

Bionic Eye Receives FDA Approval in US PDF
Submit Your News
International News
Tuesday, 19 February 2013

Argus Bionic EyeSecond Sight Medical Products, Inc., developer of retinal prostheses for the blind, has recently announced that it's Argus® II Retinal Prosthesis System ("Argus II") has received U.S. market approval from the Food and Drug Administration (FDA) to treat individuals with late stage retinitis pigmentosa (RP). This announcement follows receipt of the European approval in 2011, and a unanimous recommendation by the FDA's Ophthalmic Devices Advisory Panel in September 2012 that this revolutionary product be made available to treat this patient population in the U.S.

Argus II is intended to provide electrical stimulation of the retina to induce visual perception in blind individuals with retinitis pigmentosa and has the capacity to offer life-changing visual capabilities to those currently unable to see anything except, at best, extremely bright lights.

With approval from the FDA, the Argus II is slated to be available later this year in clinical centers across the US. Second Sight will be actively adding sites to make the therapy more readily available and encourages interested facilities and patients to contact them.

FDA approval came following more than 20 years of work in the field, two clinical trials, over US$100M in public investment by the National Eye Institute, the Department of Energy, and the National Science Foundation, and an additional US$100M in private investments.

Ocular Therapeutic Engineering Centre Launched in Singapore PDF
Submit Your News
International News
Monday, 04 February 2013

Wong - SubbuFor glaucoma patients, taking daily medication will soon become a thing of the past. Instead, with Singapore's Nanyang Technological University's (NTU) newest solution, a simple, quick and painless injection four times a year would be enough. The solution contains an anti-glaucoma drug wrapped in nano-sized capsules, and is delivered by an injection into the outer layer in the front of the eye (conjunctiva) by the doctor.

The nanocarrier will then slowly release the drug over several weeks. LipoLat, as it is known, is now ready for clinical trials. Extensive pre-clinical studies have shown that this single injection is as effective at treating glaucoma as taking daily eye drops for up to 3 months. Forgetting to administer the daily eye drops is the most common problem faced by glaucoma sufferers, and failure in taking the eyedrops correctly on a daily basis can result in a tragic and permanent loss of vision.

There are also many problems with eye drops, including allergies, unpleasant side effects, remembering to take them at the correct time, correct insertion technique, storage and hygiene. Such an innovative 'eye-dea' like LipoLat is what NTU's latest research centre, the Ocular Therapeutic Engineering Centre (OTEC), has as its mission.

Housed at NTU's School of Materials Science and Engineering, OTEC builds upon the School's successful research collaboration with the Singapore Eye Research Institute. Centre Director, Professor Subbu Venkatraman, who is also the School Chair, said the centre will build on the strong research collaboration between clinical scientists and NTU technologists, to develop new drug delivery systems for the eye.

Working closely with Prof Venkatraman (picture) as the Co-Director of the centre is Dr Tina Wong (picture), an Adjunct Associate Professor at the School of Materials Science and Engineering and a senior consultant at the Singapore National Eye Centre. She is also Head of the Ocular Therapeutics and Drug Delivery Research Group at the Singapore Eye Research Institute.

The Ocular Therapeutic Engineering Centre will have about ten full time scientists. Among its initial projects, which are individually funded by various funding sources and agencies, include an implantable device which can constantly monitor the pressure changes within the eye in real time.

Inaugural The Eye Show London Cancelled PDF
Submit Your News
International News
Friday, 01 February 2013

The Eye Show CancelledThe Inaugural The Eye Show London, which would have taken place in two weeks time, has been cancelled. As a result of the huge outstanding payments owed to the show's organiser company Emergexpo and an unsuccessful external investment,  Emergexpo cancelled the event on 30 January at 5pm.

On their website Dawn Kime, the Event Director, writes:

"It is with deep regret that I inform you that The Eye Show 2013 has been cancelled. I’m devastated that this will have caused inconvenience and cost to the exhibitors, speakers and visitors who have pre-registered to attend, and the people who have supported The Eye Show. I really have tried everything I can to resolve the matter.
A Receiver has been appointed this morning and the details are:
Stephen Grant, Wilkins Kennedy
Tel: 01494 545570"

28th Asia-Pacific Academy of Ophthalmology Congress To Be Held From Jan 17-20 PDF
Submit Your News
International News
Tuesday, 15 January 2013

The 28th Asia-Pacific Academy of Ophthalmology Congress (APAO) in conjunction with the 71st Annual Conference of All India Ophthalmological Society (AIOS) is scheduled to be held in Hyderabad at HICC (Hyderabad International Convention Centre) in Madhapur from January 17-20, 2013. The main objective of this congress is to throw light on the recent advances and latest developments in the field of ophthalmology and provide an opportunity for the participants to interact, discuss, exchange ideas with international ophthalmic experts.

AIOS is the largest association of eye surgeons in India and the second largest in the world with over 15,000 members. The three-day Congress is expected to receive about 10000 national and international delegates from across the globe.

Dr Rajvardha Azad, president APAO-AIOS-2013 informed that the big event will be inaugurated by Pranab Mukherjee, president of India. While giving more insights into the event Dr N S Reddy, senior vice president, APAO-AIOS 2013 said, “As new advancements and developments are coming up every day, it is important that the doctors should continuously upgrade their knowledge. Programmes like the APAO-AIOS will help the eye specialists in India to upgrade their knowledge. The congress will provide an opportunity for the participants from across India as well as from other nations to update their knowledge and learn the latest developments in the field of ophthalmology.”

The event will be an apt platform for doctors, researchers and scientist to discuss, deliberate and share views on various developments in the filed of ophthalmology. There will be several sessions, courses, paper presentations, etc. in all fields including basics and advances on eye and various sub-specialties viz. cataract, cornea and external eye disease, glaucoma, neuro-ophthalmology, ocular pathology tumors, orbits and oculoplastics, pediatric ophthalmology strabismus, retina, refractive surgery, intraocular inflammation, uvetis scleritis, ocular imaging, ocular microbiology and ocular infectious diseases, ophthalmic epidemiology, orbits and oculoplastics, prevention of blindness, etc.

Eyewear Design Competition Awards at HK Optical Fair PDF
Submit Your News
International News
Tuesday, 04 December 2012

Under the theme “Timeless,” the competition, organised by the Hong Kong Trade Development Council (HKTDC) and the Hong Kong Optical Manufacturers Association, saw more than 200 entries this year. Eleven prizes were awarded to nine local designers, and were displayed at HKTDC Hong Kong Optical Fair, last month.

Mag Type

OKIA Optical Company took the top prize in the Professional Group section. The champion piece, “Mag Type” by Lee Tsun Hung, borrows from the appearance of a vintage typewriter and its distinctive sound. Infusing modern elements into the classic typewriter, the spectacles uses no screws, is interchangeable and features a spring-hinge function.


Viola Pak’s creation “Chang’er,” based on the legendary Chinese goddess of the moon, took top prize in the Open Group category. The vintage-style eyewear features a rounded shape reminiscent of the moon, with patterns representing auspicious clouds. The right temple stem is made out of jade with a jade ornament adorning it.

Look Back

The winning design in the Student Group category also took the Creativity and the Made-to-Sell awards. “Look Back,” by Pang Horng from the Hong Kong Design Institute, uses contrasting colours, as well as a mixture of plastic and metal, to make the spectacles resemble the classic toy robot.

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 5 of 49